Cargando…

A novel anti-cancer effect of resveratrol: reversal of epithelial-mesenchymal transition in prostate cancer cells

Carcinoma progression is associated with the loss of epithelial features and the acquisition of a mesenchymal phenotype, a process known as epithelial-mesenchymal transition (EMT). Resveratrol, a natural polyphenolic compound found in grapes, berries and peanuts, has a wide range of pharmacological...

Descripción completa

Detalles Bibliográficos
Autores principales:	LI, JIANPING, CHONG, TIE, WANG, ZIMING, CHEN, HAIWEN, LI, HECHENG, CAO, JUN, ZHANG, PENG, LI, HONGLIANG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148361/ https://www.ncbi.nlm.nih.gov/pubmed/25069516 http://dx.doi.org/10.3892/mmr.2014.2417

Ejemplares similares

Over-expression of a poor prognostic marker in prostate cancer: AQP5 promotes cells growth and local invasion
por: Li, Jianping, et al.
Publicado: (2014)

Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors
por: Guo, Kaibo, et al.
Publicado: (2021)

Induction of the Epithelial-to-Mesenchymal Transition of Human Colorectal Cancer by Human TNF-β (Lymphotoxin) and its Reversal by Resveratrol
por: Buhrmann, Constanze, et al.
Publicado: (2019)

High expression of ladinin-1 (LAD1) predicts adverse outcomes: a new candidate docetaxel resistance gene for prostatic cancer (PCa)
por: Li, Jianping, et al.
Publicado: (2021)

Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer
por: Xu, Jiahui, et al.
Publicado: (2017)

MDM2 and P53 polymorphisms contribute together to the risk and survival of prostate cancer
por: Xue, Li, et al.
Publicado: (2015)

Resveratrol Sensitizes Tamoxifen in Antiestrogen-Resistant Breast Cancer Cells with Epithelial-Mesenchymal Transition Features
por: Shi, Xiao-Peng, et al.
Publicado: (2013)

Epithelial-mesenchymal transition in prostate cancer: an overview
por: Montanari, Micaela, et al.
Publicado: (2017)

Correction: Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/ Akt signaling pathway in gastric cancer
por: Xu, Jiahui, et al.
Publicado: (2023)

SCAND1 Reverses Epithelial-to-Mesenchymal Transition (EMT) and Suppresses Prostate Cancer Growth and Migration
por: Eguchi, Takanori, et al.
Publicado: (2022)

Resveratrol Inhibits Cisplatin-Induced Epithelial-to-Mesenchymal Transition in Ovarian Cancer Cell Lines
por: Baribeau, Sébastien, et al.
Publicado: (2014)

SATB1 promotes epithelial-mesenchymal transition and metastasis in prostate cancer
por: Qi, Honggang, et al.
Publicado: (2017)

Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial- mesenchymal transition via the AKT/GSK-3β/Snail signaling pathway
por: Yuan, Li, et al.
Publicado: (2019)

Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial-mesenchymal transition via the AKT/GSK-3β/Snail signaling pathway
por: Yuan, Li, et al.
Publicado: (2022)

Anti-Cancer Potential of Phytochemicals: The Regulation of the Epithelial-Mesenchymal Transition
por: Liu, Shuangyu, et al.
Publicado: (2023)

MicroRNAs and epithelial-mesenchymal transition in prostate cancer
por: Sekhon, Kirandeep, et al.
Publicado: (2016)

MLPH Accelerates the Epithelial–Mesenchymal Transition in Prostate Cancer
por: Zhang, Tianbiao, et al.
Publicado: (2020)

Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer
por: Di Zazzo, Erika, et al.
Publicado: (2019)

Resveratrol Suppresses Epithelial-Mesenchymal Transition in GBM by Regulating Smad-Dependent Signaling
por: Song, Yang, et al.
Publicado: (2019)

Resveratrol promotes trophoblast invasion in pre‐eclampsia by inducing epithelial‐mesenchymal transition
por: Zou, Yanfen, et al.
Publicado: (2019)

Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells
por: Chen, Shuo, et al.
Publicado: (2018)

Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells
por: Chen, Shuo, et al.
Publicado: (2022)

Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition
por: Sun, Yang, et al.
Publicado: (2019)

LncRNA DIO3OS regulated by TGF-β1 and resveratrol enhances epithelial mesenchymal transition of benign prostatic hyperplasia epithelial cells and proliferation of prostate stromal cells
por: Chen, Yanbo, et al.
Publicado: (2021)

The Role and Mechanism of Epithelial-to-Mesenchymal Transition in Prostate Cancer Progression
por: Lo, U-Ging, et al.
Publicado: (2017)

Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition
por: Chen, Chen, et al.
Publicado: (2019)

Inhibition or Reversal of the Epithelial-Mesenchymal Transition in Gastric Cancer: Pharmacological Approaches
por: Kozak, Joanna, et al.
Publicado: (2020)

Resveratrol Reverses Cigarette Smoke-Induced Urocystic Epithelial–Mesenchymal Transition via Suppression of STAT3 Phosphorylation in SV-HUC-1-Immortalized Human Urothelial Cells
por: Sun, Hongliang, et al.
Publicado: (2019)

Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells
por: Kong, Dejuan, et al.
Publicado: (2012)

Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancer
por: Li, Ping, et al.
Publicado: (2014)

Reversion of epithelial-mesenchymal transition by a novel agent DZ-50 via IGF binding protein-3 in prostate cancer cells
por: Cao, Zheng, et al.
Publicado: (2017)

Reversal of Epithelial–Mesenchymal Transition by Natural Anti-Inflammatory and Pro-Resolving Lipids
por: Lee, Chang Hoon
Publicado: (2019)

Matrine inhibits prostate cancer via activation of the unfolded protein response/endoplasmic reticulum stress signaling and reversal of epithelial to mesenchymal transition
por: Chang, Junli, et al.
Publicado: (2018)

Detection of Epithelial-Mesenchymal Transition Status of Circulating Tumor Cells in Patients with Esophageal Squamous Carcinoma
por: Han, Dingpei, et al.
Publicado: (2018)

Anti-S100A4 antibody administration alleviates bronchial epithelial–mesenchymal transition in asthmatic mice
por: Liu, Shuang, et al.
Publicado: (2023)

WTX inhibits gastric cancer migration through the reversal of epithelial-mesenchymal transition
por: Ye, Danli, et al.
Publicado: (2018)

Vitamin D Enhances Radiosensitivity of Colorectal Cancer by Reversing Epithelial-Mesenchymal Transition
por: Yu, Xinyue, et al.
Publicado: (2021)

Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer
por: Kolijn, Kimberley, et al.
Publicado: (2015)

Altered expression of epithelial-to-mesenchymal transition proteins in extraprostatic prostate cancer
por: Verrill, Clare, et al.
Publicado: (2015)

Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway
por: Zang, Ming-de, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vutc0uuale0j744dlk724fqvc8